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Summary  30 
Faecal samples from 1365 healthy asymptomatic volunteers from four regions in England 31 
were screened for the presence of Clostridium difficile between December 2013 and July 32 
2014. The carriage rate of C. difficile in healthy patients was 0.5%, which is lower than 33 
previously reported. This study demonstrates that the true community reservoir of C. difficile 34 
in the healthy UK population is very low and is, therefore, unlikely to be a reservoir for 35 
infections diagnosed in the hospital setting. 36 
 37 
Introduction 38 
Clostridium difficile infection (CDI) is primarily considered to be a hospital-associated 39 
infection most prominent amongst the elderly; it is a major problem in health care settings 40 
and nursing homes, causing a wide spectrum of illness ranging from mild diarrhoea to 41 
pseudomembranous colitis1. Use of broad spectrum antibiotics alters the commensal bacterial 42 
flora allowing C. difficile spores to germinate, colonise the gut and produce enterotoxins. 43 
Numerous studies have investigated the carriage rate of C. difficile in subjects in the 44 
community; however, they have primarily looked at elderly subjects, who are more prone to 45 
acquiring CDI due to increased hospital visits and antibiotic usage, or have looked at samples 46 
from subjects that have diarrhoea2-4. Two large studies looking at the incidence of infectious 47 
intestinal diseases in the community showed low incident rates of CDI, however, patient 48 
samples were only screened when there were symptoms of sickness or diarrhoea5;6. Other 49 
Clostridia species are present in faeces, one of which, Clostridium hathewayi was first 50 
isolated from human faeces  and described as a new species in 2001 and then reclassified as 51 
Hungatella hathewayi in 2014 7 Unlike C. difficile, there have been very few reported cases 52 
of human infection caused by Hungatella hathewayi 8 and little is known about the incidence 53 
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of carriage and the potential for infection. In this structured and stratified study we aimed to 54 
determine the carriage rate of C. difficile and observe the prevalence of H. hathewayi in 55 
healthy volunteers from four demographically diverse regions of the United Kingdom.  56 
Methods 57 
Subject recruitment 58 
Randomly selected patients aged 18 plus registered with fourteen community healthcare 59 
practices within four National Health Service (NHS) Primary Care Trusts (PCTs) in England 60 
were invited by post to submit a faecal sample to “culture the different bacteria in our gut”. 61 
The PCTs were non-randomly selected, each to represent a section of the population with a 62 
different ethnic composition: Newham (in London with one of the most mixed ethnic 63 
compositions in the UK), Heart of Birmingham (predominantly Asian population), 64 
Shropshire (rural, almost entirely white British population) and Southampton City (mixed 65 
ethnicity). Patient lists from the fourteen community healthcare practices were randomised 66 
and stratified according to antibiotic use in the previous twelve months, gender and ethnic 67 
groups; patients were then invited in order from these lists to participate. A total of 42,355 68 
invitations were sent out to patients on the lists up to the end of July 2014, with 2865 69 
accepting the invitation to participate. Between December 2013 and July 2014, faecal 70 
samples from 1365 invitees (44% men; 56% women), aged 18-97 with an average age of 58 71 
(Aged 18-49: 30%; 50-65: 32%; 66-75: 23% and 15% were ≥75 years), were screened for the 72 
presence of C. difficile by culture. Antibiotic usage was obtained by questionnaire from each 73 
patient. This study was approved by The National Research Ethic committee, reference 74 
number 13/SW/0017.   75 
 76 
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C. difficile culture and identification 77 
A pea-sized amount of stool, which had previously been frozen at -80oC, was treated with 78 
0.5ml of 100% ethanol, homogenised using a vortex mixer and incubated at room 79 
temperature for 30 mins. One hundred microliters of the treated specimen was inoculated 80 
onto C. difficile ChomID media (BioMerieux).  Plates were incubated at 37ºC under 81 
anaerobic conditions for 24hrs read and then reincubated for a further 24hrs (48hrs in total). 82 
Multiple colony picks of presumptive positive isolates, identified by colony colour and 83 
morphology, were purity plated onto Columbia blood agar and incubated for 48hrs at 37oC 84 
anaerobically. Each of these colonies were then identified from a single colony pick using 85 
MALDI-TOF (Bruker Daltonik MALDI Biotyper).  86 
PCR-Ribotyping 87 
All isolates confirmed as C. difficile were ribotyped. Crude DNA extracts of C. difficile were 88 
prepared using the chelex extraction method. For PCR-ribotyping two microliters of extracted 89 
DNA were added to 18µl PCR mastermix to give final concentrations of 1x Qiagen HotStar 90 
Taq Plus master mix (Qiagen) and 0.1pmol/µl each primer as described by Janezic et al9 .  91 
 92 
The reaction mixes were subjected to an initial polymerase activation step at 95oC for 5 min 93 
followed by 26 cycles of 95oC for 1 min, 55oC for 1.5 min and 72oC for 1 min followed by 94 
95oC for 1 min, 55oC for 45 sec and a final elongation step of 72oC for 30 min. PCR products 95 
were diluted 1 in 20 in molecular grade water and 1µl aliquots of the DNA mixes were mixed 96 
with 9µl aliquots of HiDi formamide-LIZ600 size standard (Applied Biosystems) at 44:1 97 
(vol/vol), denatured by heating to 95oC for 5 min, and transferred to a 3130xl genetic 98 
analyzer (Applied Biosystems) for PCR product size determination by capillary 99 
electrophoresis. PCR fragment profiles were analyzed using GeneMapper v4.0 software 100 
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(Applied Biosystems) and fragment sizes exported to BioNumerics v5.1 (Applied Maths NV, 101 
Sint-Martens-Latem, Belgium) for ribotype assignment by comparison with a library of 102 
known PCR fragment profiles.  103 
  104 
Results 105 
Based on colony colour there were 39/1365 (2.8%) presumptive positives after 24hrs 106 
incubation and 393/1365 (28.8%) after 48hrs, of which 5 did not grow on Columbia blood 107 
agar.  Of the remaining 388 isolates, MALDI-TOF identified 360 isolates as members of the 108 
Clostridia family, with the exception of 1 isolate which was Dichelobacter nodus (Table I). 109 
The other 28 isolates could not be identified by MALDI-TOF. Seven isolates were C. 110 
difficile, (0.5% of total screened) with the majority of isolates (337/360) being Hungatella 111 
hathewayi. Ribotyping of the seven isolates identified two isolates with an indistinguishable 112 
ribotype, ribotype 026, which is a non-toxigenic strain. The five other isolates all had distinct 113 
ribotypes, four of which were common UK strains, ribotypes 002, 014, 015 and 020. The 114 
final isolate did not match any of the profiles in our locally held database, and is, therefore, 115 
not likely to be a commonly occurring UK ribotype. Six of the seven C. difficile isolates were 116 
from the Newham region of London, but all had distinct unrelated ribotypes.  Four of the 117 
seven patients were in their 40s with the other three patients being in their 60s. In the 118 
preceding year, five of the seven patients had been treated with antibiotics, including 119 
amoxicillin, whilst the other two patients did not know if they had taken antibiotics. 120 
 121 
Discussion 122 
The point prevalence of C. difficile, within the healthy community population observed in 123 
this study was 7/1365 (0.51%), with only 5/1365 (0.37%) being toxigenic C. difficile. Similar 124 
low rates have also been observed in the UK infectious intestinal disease (IID) population 125 
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cohort studies that took place in 1999 and 2008/9. In 1999 only 6 cases of C. difficile were 126 
detected from 9,776 patients recruited 5 and none in 2008/09 6. The IID studies included 127 
healthy people from community healthcare practices, but unlike the current study samples 128 
were only sent when the patient had symptoms of diarrhoea or vomiting. 129 
The main differences between this study and those that have shown a higher prevalence of C. 130 
difficile is the age of the study population (27% ≥70 years with a median age of 60 in our 131 
study compared to 100% ≥70 years with a median age of 81 in the Miyajima et al. study2) 132 
and the inclusion of asymptomatic healthy volunteers2-4.  Previous community studies where 133 
the age of the study population was more elderly 2 have reported carriage rates of 4% 134 
(6/149)and 1.6% respectively4. In a study which screened samples from community patients 135 
with diarrhoea, which would include community cases of CDI, the rate was 2% 3. C. difficile 136 
infection is much more common in the elderly population, due to the increased likelihood of 137 
antibiotic usage, hospital admissions, nursing home residence and loss of gut microbiota 138 
diversity4.  139 
ChromID media provides a rapid, sensitive medium for screening for C. difficile, due to the 140 
formation of black/grey colonies, allowing easy detection within 24 hours. However, similar 141 
to the study by Eckert and colleagues 10, the sensitivity of the media was improved by reading 142 
at 48hrs as three of the seven C. difficile isolates were detected, but did result in a much 143 
reduced specificity with a tenfold increase in the number of other Clostridium species being 144 
isolated (Table 1). This has been described in previous studies, where they also show a lower 145 
specificity in comparison to other media used to isolate C. difficile10. Hungatella hathewayi 146 
was the predominant organism isolated, with approximately 25% of the 1365 volunteers 147 
carrying it; accounting for 87% of the presumptive positives identified. There are a few 148 
reports of  Hungatella hathewayi causing clinical disease, including bacteraemia8, but no 149 
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studies of its prevalence in the faecal flora. Whilst it rarely causes disease it appears to be a 150 
common faecal flora commensal. 151 
 152 
Conclusion 153 
This study shows that the prevalence of C. difficile carriage in the asymptomatic healthy 154 
population is very low. Previous studies have shown higher carriage rates but this is probably 155 
due to sample groups being comprised of only elderly volunteers or samples from 156 
symptomatic patients. This suggests that the likelihood of the healthy community being a 157 
reservoir for infection is low unless the individual has been on a course of antibiotics or had a 158 
recent admission to hospital, predisposing them to increased chance of C. difficile colonising 159 
the gut.  160 
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 198 
Table I. MALDI-TOF identification of the 388 positive isolates isolated from ChromID 199 
media after 24 and 48 hours incubation. 200 
Organism identified Initial No of 
isolates after 
24hr  
Further No of 
isolates after 
48hr 
Total number 
of isolates 48hr  
Clostridium difficile 4 3 7 
Clostridium baratii 0 1 1 
Clostridium disporicum 2 3 5 
Hungatella hathewayi  19 318 337 
Clostridium perfringens  3 0 3 
Clostridium tertium 0 3 3 
Clostridium species 2 1 3 
Dichelobacter nodosus 1 0 1 
No peaks or Unidentifiable 7 21 28 
Total 38 350 388 
